Evidence-Based Management of Alzheimer’s Disease: Best Practices and Future Directions

Released On
May 1, 2019

Expires On
May 1, 2020

Media Type
Internet

Completion Time
60 minutes

Specialty
Neurologists, Family Physicians, Primary Care Physicians

Topic(s)
Alzheimer’s Disease

Scroll to the Bottom of this Information to Begin this Course

This activity is provided by the Potomac Center for Medical Education.

 

Supported by an educational grant from Biogen.

 

Credit Available

  • Physicians — maximum of 1.0 AMA PRA Category 1 Credit(s)

All other healthcare professionals completing this course will be issued a statement of participation.

Target Audience

This activity is intended for neurologists and other healthcare professionals who manage patients with Alzheimer’s disease.

Program Overview

Many patients with Alzheimer’s disease (AD) experience delayed diagnoses, which deprives them and their caregivers of interventions that can extend cognitive integrity and quality of life, delay placement in long-term care, minimize burden on caregivers, and reduce overall costs. The lack of disease-modifying agents for AD contributes to clinical inertia and leads clinicians to overlook adjunctive therapies for comorbidities and behavioral and psychological problems.

Evidence-based Management of Alzheimer’s Disease: Best Practices and Future Directions,” will reinforce the need for early recognition of mild cognitive impairment and early cognitive decline. The activity will review the profiles of current and emerging AD treatment options and discuss the implementation of multidisciplinary collaborative care to provide the best possible outcomes for patients with AD.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Describe the critical importance of early recognition of mild cognitive impairment and early cognitive decline
  • Outline the mechanisms of action, efficacy and safety profiles, and places in treatment regimens of current and emerging treatment options for Alzheimer’s disease
  • Describe neurologist-led initiatives to establish multidisciplinary collaborative-care models for Alzheimer’s disease and action-based steps for implementation of similar programs

Faculty

Marwan N. Sabbagh, MD, FAAN, CCRI

Camille and Larry Ruvo Endowed Chair for Brain Health
Director, Cleveland Clinic Lou Ruvo Center for Brain Health
Las Vegas, NV

R. Scott Turner, MD, PhD

Professor of Neurology and Director
Memory Disorders Program
Georgetown University Medical Center
Washington, DC

Accreditation Statement

The Potomac Center for Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation

The Potomac Center for Medical Education designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Disclosures of Conflicts of Interest

The Potomac Center for Medical Education (PCME) adheres to the policies and guidelines, including the Standards for Commercial Support, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous.

All persons in a position to control the content of a continuing medical education program provided by PCME are required to disclose any relevant financial relationships with any commercial interest to PCME as well as to learners. All conflicts of interest are identified and resolved by PCME in accordance with the Standards for Commercial Support in advance of delivery of the activity to learners. Disclosures will be made known to the participants prior to the activity.

The content of this activity was vetted by an external reviewer to assure objectivity and that the activity is free of commercial bias.

Steering Committee
The steering committee reported the following relevant financial relationships that they or their spouse/partner have with commercial interests:

Marwan N. Sabbagh, MD, FAAN, CCRI

  • Consultant/Independent Contractor: Allergan, Biogen, Bracket, Cortexyme, Grifols, Neurotrope, Roche-Genentech
  • Stock Shareholder: Brain Health Inc., uMethod Health, Versanum Inc.

R. Scott Turner, MD, PhD

  • Grant/Research Support: Biogen, Genentech/Roche, Lilly, Merck, Novartis

Non-faculty Content Contributors
Non-faculty content contributors and/or reviewers reported the following relevant financial relationships that they or their spouse/partner have with commercial interests:

Chad Williamson, MS, MBA, CMPP; Blair St. Amand; Ashley Marostica MSN, RN, CCM: Nothing to disclose.

Disclosure of Unlabeled Use

The contents of some CME/CE activities may contain discussions of non-approved or off-label uses of some agents mentioned. Please consult the prescribing information for full disclosure of approved uses.

Method of Participation

There are no fees to participate in the activity. Participants must review all activity information, including the learning objectives, disclosure statements, and content. To receive credit for participation, participants must complete the post-test (achieving a passing grade) and program evaluation. Certificates can be printed immediately.

Course Viewing Requirements

Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above

Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above.